{"created":"2024-05-23T06:22:45.371282+00:00","id":2003026,"links":{},"metadata":{"_buckets":{"deposit":"7f5d29b9-4544-43c1-bc75-3a60fc52b859"},"_deposit":{"created_by":7,"id":"2003026","owners":[7],"pid":{"revision_id":0,"type":"depid","value":"2003026"},"status":"published"},"_oai":{"id":"oai:jair.repo.nii.ac.jp:02003026","sets":["1616224532673:1708403533383:1709527895277:1709529724726"]},"author_link":[],"item_10006_alternative_title_1":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_alternative_title":"(HER2陽性転移性乳がん患者における臨床病理学的因子のトラスツズマブ・デルクステカンの有効性への影響)","subitem_alternative_title_language":"ja"}]},"item_10006_date_granted_11":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2023-03-20"}]},"item_10006_degree_grantor_9":{"attribute_name":"item_10006_degree_grantor_9","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"順天堂大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"32620","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_10006_degree_name_8":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）","subitem_degreename_language":"ja"}]},"item_10006_description_10":{"attribute_name":"学位授与年度","attribute_value_mlt":[{"subitem_description":"2022年度","subitem_description_language":"ja","subitem_description_type":"Other"}]},"item_10006_dissertation_number_12":{"attribute_name":"dissertation_number","attribute_value_mlt":[{"subitem_dissertationnumber":"甲第2711号"}]},"item_10006_relation_15":{"attribute_name":"関連サイト","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1016/j.breast.2022.01.002","subitem_relation_type_select":"DOI"}}]},"item_10006_version_type_18":{"attribute_name":"出版タイプ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"中島, 裕理","creatorNameLang":"ja"},{"creatorName":"ナカジマ, ヒロミチ","creatorNameLang":"ja-Kana"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-06-19"}],"displaytype":"detail","filename":"MDK2711-sinyou.pdf","filesize":[{"value":"157.2 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"審査結果の要旨","objectType":"other","url":"https://jair.repo.nii.ac.jp/record/2003026/files/MDK2711-sinyou.pdf"},"version_id":"aad744c2-6ae6-460f-b96d-e7fb75a32bd1"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-06-19"}],"displaytype":"detail","filename":"MDK2711-ronyou.pdf","filesize":[{"value":"129.3 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"論文内容の要旨","objectType":"abstract","url":"https://jair.repo.nii.ac.jp/record/2003026/files/MDK2711-ronyou.pdf"},"version_id":"ff453017-9ab4-4733-b855-513901565544"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-06-19"}],"displaytype":"detail","filename":"MDK2711-zenbunpu.pdf","filesize":[{"value":"867.5 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"全文【出版社版】","objectType":"fulltext","url":"https://jair.repo.nii.ac.jp/record/2003026/files/MDK2711-zenbunpu.pdf"},"version_id":"c868bcf5-b3f4-45e3-8a36-f28d1ea6cbb7"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"item_resource_type","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_title":"Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer","subitem_title_language":"en"}]},"item_type_id":"40001","owner":"7","path":["1709529724726"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2023-06-19"},"publish_date":"2023-06-19","publish_status":"0","recid":"2003026","relation_version_is_last":true,"title":["Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer"],"weko_creator_id":"7","weko_shared_id":-1},"updated":"2024-11-26T04:18:34.274020+00:00"}